|
 Glenn Chin, the now-defunct New England Compounding Center's
supervisory pharmacist, was sentenced for a second time by U.S.
District Judge Richard Stearns in Boston two weeks after co-founder
Barry Cadden received a new prison term of 14-1/2 years.
Both men were separately convicted in 2017 of racketeering and fraud
over misrepresentations to NECC customers about its drugs but were
cleared of second-degree murder charges related to 25 patients'
deaths.
Prosecutors said those deaths stemmed from a fungal meningitis
outbreak traced back to mold-tainted steroids that Framingham,
Massachusetts-based NECC produced in filthy and unsafe conditions
and sold to hospitals and clinics nationally.
The outbreak sickened 793 patients, more than 100 of whom died.
Prosecutors said Chin, while supervising the so-called clean rooms
in which NECC's drugs were made, directed staff to ship untested
drugs, use expired ingredients, falsify cleaning logs and ignore
mold and bacteria.
Chin, speaking from a jail cell, said he never intended for the
contamination but had allowed for "shortcuts I knew were wrong."
[to top of second column] |
"I feel responsible for what happened because I made the drugs that
made so many people terribly sick, including those who have died,"
he said.
Stearns originally sentenced Cadden, NECC's co-owner and president,
and Chin to nine and eight years, respectively, prompting a
successful appeal by prosecutors who considered the penalties too
lenient. Prosecutors had initially sought 35-year prison terms for
both men.
Stearns on Wednesday also ordered Chin to jointly with Cadden pay
$82 million in restitution to their victims and forfeit $473,584 to
the government.
Both men are now awaiting trial on separate second-degree murder
charges in Michigan, which was hit hard by the outbreak.
(Reporting by Nate Raymond in Boston; Editing by Steve Orlofsky)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
 |
